| Richard P Gaskill, MD | |
|
9977 Woods Dr, Skokie, IL 60077-1057 | |
| (847) 663-8420 | |
| (847) 663-1018 |
| Full Name | Richard P Gaskill |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 49 Years |
| Location | 9977 Woods Dr, Skokie, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316986599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | 036053561 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excel Care Health Services, Inc | Lincolnwood, IL | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Onsite Health Specialty Physicians, Inc | 1850708892 | 6 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
Cancer Research UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer lung cancer, and determine the type of lung cancer that develops. Their results were published in this week's edition of the journal Cancer Research*.
Nuline Pharmaceuticals, LLC announces the introduction of REMESENSE (dipotassium oxalate 3%) TOOTH DESENSITIZER, an Rx Class II medical device now available in the U.S. REMESENSE was introduced globally in 2008. It is presently sold in 16 countries, ranging from England and the European Union to Asia and Africa. Nuline expects to launch REMESENSE in Canada and other countries later this year or by early 2011.
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared online in Scientific Reports.
› Verified 5 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
Cancer Research UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer lung cancer, and determine the type of lung cancer that develops. Their results were published in this week's edition of the journal Cancer Research*.
Nuline Pharmaceuticals, LLC announces the introduction of REMESENSE (dipotassium oxalate 3%) TOOTH DESENSITIZER, an Rx Class II medical device now available in the U.S. REMESENSE was introduced globally in 2008. It is presently sold in 16 countries, ranging from England and the European Union to Asia and Africa. Nuline expects to launch REMESENSE in Canada and other countries later this year or by early 2011.
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared online in Scientific Reports.
› Verified 5 days ago
| Entity Name | Onsite Healthcare Inc Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740585579 PECOS PAC ID: 1153505565 Enrollment ID: O20110408000722 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
Cancer Research UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer lung cancer, and determine the type of lung cancer that develops. Their results were published in this week's edition of the journal Cancer Research*.
Nuline Pharmaceuticals, LLC announces the introduction of REMESENSE (dipotassium oxalate 3%) TOOTH DESENSITIZER, an Rx Class II medical device now available in the U.S. REMESENSE was introduced globally in 2008. It is presently sold in 16 countries, ranging from England and the European Union to Asia and Africa. Nuline expects to launch REMESENSE in Canada and other countries later this year or by early 2011.
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared online in Scientific Reports.
› Verified 5 days ago
| Entity Name | Onsite Health Specialty Physicians, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265024194 PECOS PAC ID: 1850708892 Enrollment ID: O20210318001615 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
Cancer Research UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer lung cancer, and determine the type of lung cancer that develops. Their results were published in this week's edition of the journal Cancer Research*.
Nuline Pharmaceuticals, LLC announces the introduction of REMESENSE (dipotassium oxalate 3%) TOOTH DESENSITIZER, an Rx Class II medical device now available in the U.S. REMESENSE was introduced globally in 2008. It is presently sold in 16 countries, ranging from England and the European Union to Asia and Africa. Nuline expects to launch REMESENSE in Canada and other countries later this year or by early 2011.
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared online in Scientific Reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard P Gaskill, MD 3926 W Touhy Ave, # 372, Lincolnwood, IL 60712-1028 Ph: (847) 730-7098 | Richard P Gaskill, MD 9977 Woods Dr, Skokie, IL 60077-1057 Ph: (847) 663-8420 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
Cancer Research UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer lung cancer, and determine the type of lung cancer that develops. Their results were published in this week's edition of the journal Cancer Research*.
Nuline Pharmaceuticals, LLC announces the introduction of REMESENSE (dipotassium oxalate 3%) TOOTH DESENSITIZER, an Rx Class II medical device now available in the U.S. REMESENSE was introduced globally in 2008. It is presently sold in 16 countries, ranging from England and the European Union to Asia and Africa. Nuline expects to launch REMESENSE in Canada and other countries later this year or by early 2011.
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared online in Scientific Reports.
› Verified 5 days ago
Casimiro Agulo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 8800 Lockwood, Skokie, IL 60077 Phone: 847-983-1400 Fax: 847-966-8071 | |
Peggy Wang, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 8800 Lockwood Ave, Skokie, IL 60077 Phone: 847-983-1400 Fax: 847-966-8071 | |
Chunliu Zhu, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr Ste 100, Skokie, IL 60077 Phone: 224-364-2273 | |
Dr. Mohammed Abdul-rahman Khan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr Ste 100, Skokie, IL 60077 Phone: 224-364-2273 Fax: 847-663-8290 | |
Dr. Tatiana Claudia Doyle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr Ste 100, Skokie, IL 60077 Phone: 224-364-2273 | |
Dr. May Hassib, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr Ste 100, Skokie, IL 60077 Phone: 224-251-2273 | |
Dr. Kirsten Eileen Geary, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9650 Gross Point Rd Ste 2900, Skokie, IL 60076 Phone: 847-886-7846 Fax: 224-251-2905 |